My watch list
my.bionity.com  
Login  
NEWS
Current news

Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells

A pilot study by Associate Professor Pilar Blancafort, a member of the Harry Perkins Institute of Medical Research, shows that Phylogica’s cell penetrating peptides (CPPs) linked with the Omomyc drug kill aggressive drug resistant breast cancer cells in vivo.Professor Blancafort also observ ... more

UCB secures multimillion pound funding boost from UK Government

UCB announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.The win ... more

Does glyphosate cause cancer?

In its recent evaluation from March 2015, the International Agency for Cancer Research (IARC), as the specialized cancer agency of the World Health Organization (WHO), came to the conclusion that glyphosate should now be classified as a carcinogenic substance in Group 2A (probably carcinoge ... more

Fecal transplants successful for treating C. difficile infection

Distasteful though it sounds, the transplantation of fecal matter is more successful for treating Clostridium difficile infections than previously thought. The research, published in Microbiome, reveals that healthy changes to a patient's microbiome are sustained for up to 21 weeks after tr ... more

Antibiotic resistance risk for coastal water users

Recreational users of coastal waters such as swimmers and surfers are at risk of exposure to antibiotic resistant bacteria, according to new research. In the first study of its kind, scientists at the University of Exeter Medical School have assessed the amount of water ingested during diff ... more

Rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens

Toshiba Ltd and Kawasaki City Institute for Public Health collaborate in the development of a rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens for applications in hygiene management in food manufacture, pharmaceuticals, and cosmetics. The researcher ... more

Taconic Biosciences and Cellaria Biosciences collaborate to facilitate xenograft use in oncology research

Taconic Biosciences and Cellaria Biosciences announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s methodologies ... more

apceth Initiates Phase II Clinical Trial for Engineered Cell Therapy to Treat Gastrointestinal Cancer

apceth announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich.  To the company’s knowledge, thi ... more

Ebola whole virus vaccine shown effective, safe in primates

An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.The vaccine, described in the journal Science, was developed by a group led by Yoshihiro Kawaoka, a University of Wisconsin-Madison e ... more

Designer's toolkit for dynamic DNA nanomachines

The latest DNA nanodevices created at the Technische Universitaet Muenchen (TUM) - including a robot with movable arms, a book that opens and closes, a switchable gear, and an actuator - may be intriguing in their own right, but that's not the point. They demonstrate a breakthrough in the s ... more

All news

Rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens

Toshiba Ltd and Kawasaki City Institute for Public Health collaborate in the development of a rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens for applications in hygiene management in food manufacture, pharmaceuticals, and cosmetics. The researcher ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

Technology Partnership between Berthold Technologies & Biametrics

Berthold Technologies has recently established a co-operation with its new technology partner Biametrics GmbH. A spin-off of Tübingen University, Biametrics develops novel solutions for label-free analysis of bio-interactions. The 1λ-Reflectometric Interference Detection (1λ-RIDe) is the mi ... more

Huntingdon Life Sciences and Harlan Laboratories to operate under new brand and name

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations. One of the world’s leadin ... more

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests

As the era of personalized medicine dawns on healthcare, the need to understand an individual’s genetic information through genomic testing has risen. This emerging branch of medicine has given birth to multiple companies that provide genetic tests to help end users understand their genetic ... more

The promiscuity of chemical probes discovered

Researchers at IMIM (Hospital del Mar Medical Research Institute) have applied a new computational methodology to anticipate the degree of selectivity of the molecules that are used to study protein functions and reduce the risk of establishing erroneous relations between proteins and disea ... more

Eurofins acquires BioDiagnostics, Inc.

Eurofins Scientific announces the acquisition of BioDiagnostics Inc. (BDI), seed and plant-tissue testing laboratories serving the agricultural industry in the US.Founded in 1996, BDI employs 120 staff at its laboratory in River Falls, WI. BDI offers genetic, seed quality, as well as analyt ... more

Mutation detection in human in vitro fertilized embryos using whole-genome sequencing

Pre-implantation genetic diagnosis (PGD) is used in fertility clinics to detect large chromosomal abnormalities or genetic mutations passed on by parents to their in vitro fertilized (IVF) embryos. However, it is not possible to comprehensively scan the embryo's genome to detect spontaneous ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

Plasticell wins £1.6 million funding

Plasticell has announced that Innovate UK has made a further investment in a therapeutic programme utilising CombiCult®, the high throughput stem cell technology designed to solve bottlenecks in regenerative medicine development. Innovate UK will provide a grant of approximately £1.3 millio ... more

All news on bioanalytics

Taconic Biosciences and Cellaria Biosciences collaborate to facilitate xenograft use in oncology research

Taconic Biosciences and Cellaria Biosciences announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s methodologies ... more

Designer's toolkit for dynamic DNA nanomachines

The latest DNA nanodevices created at the Technische Universitaet Muenchen (TUM) - including a robot with movable arms, a book that opens and closes, a switchable gear, and an actuator - may be intriguing in their own right, but that's not the point. They demonstrate a breakthrough in the s ... more

CONTACT2015: 15th Life Science Job Fair in Heidelberg

On April 22 2015, BioContact e.V. will be organizing the CONTACT2015, the biggest life science job fair in the Rhine-Neckar region, for the 15th time in succession. 29 companies will attend the fair in the Communications Center of the German Cancer Research Center (DKFZ) in Heidelberg betwe ... more

Ablynx extends ion channel research collaboration with Merck & Co.

Ablynx announced an extension of its initial two-year research collaboration with Merck & Co., Inc., known as MSD outside the United States and Canada, to develop and commercialise Nanobody® candidates directed towards an undisclosed voltage gated ion channel.Merck & Co., Inc. will extend t ... more

Evolva and Valent BioSciences to co-develop agricultural bioactives

Evolva and Valent BioSciences Corporation (VBC), a subsidiary of Sumitomo Chemical Company, have signed an exclusive agreement to co-develop and commercialise a class of high-value active ingredients for use as next-generation agricultural bioactives. For competitive reasons, the ingredient ... more

Tiny bio-robot is a germ suited-up with graphene quantum dots

As nanotechnology makes possible a world of machines too tiny to see, researchers are finding ways to combine living organisms with nonliving machinery to solve a variety of problems. Like other first-generation bio-robots, the new nanobot engineered at the University of Illinois at Chicago ... more

Rigontec GmbH raises €4.8m in a second closing of its Series A financing

Rigontec GmbH announced it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor. The new investment brings the total Series A t ... more

The bioeconomy – lead theme for BIOTECHNICA 2015

A topic of global significance will be at the top of the agenda at BIOTECHNICA 2015 (6 to 8 October): the bioeconomy. A bio-based economy offers the opportunity to combine economic growth with care for the environment. Bio-based technologies allow us to develop more efficient production met ... more

Bone Therapeutics treats first patients in ALLOB® phase IIA spinal fusion trial

Bone Therapeutics announced that the first four patients in the phase IIA proof-of-concept study for spinal fusion procedures have been treated with Bone Therapeutics’ allogeneic osteoblastic (bone-forming) cell therapy product, ALLOB®.                                                        ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

All news on biotechnology

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

Roche acquires Signature Diagnostics

Roche announced the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are cons ... more

New Endoscopic Technique

Fluorescence lifetime imaging (FLIM) of tissue autofluorescence has been shown to provide labelfree contrast between different types and states of tissue. Clinical FLIM can combine lifetime contrast with morphological information to provide a direct comparison between different spatial regi ... more

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis announces that it is in the testing phase of a Rapid Ebola Virus Triage Test that it is developing in association with Janssen Diagnostics and the Institute for Tropical Medicine in Antwerp (Belgium) for its Idylla™ system. The Rapid Ebola Virus Triage Test is designed to enable h ... more

Eurofins acquires of Boston Heart Diagnostics Corporation

Eurofins Scientific announces the successful closing of the transaction to acquire Boston Heart Diagnostics Corp. (Boston Heart) following review and approval from relevant regulatory bodies.Eurofins signed an agreement to acquire Boston Heart for an initial cash amount US$140 million, plus ... more

Premaitha Health receives ISO 13485:2003 certification

Premaitha Health plc  announced that it has met two key requirements for obtaining a CE-mark for its IONA® test: ISO 13485:2003 certification and a successful audit of Annex IV of the In Vitro Diagnostic Medical Device Directive (98/79/EC). The ISO 13485:2003 certification confirms that Pre ... more

All news on diagnostics

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

Merck announced that it has obtained antitrust clearance from the United States Federal Trade Commission (FTC) for its planned acquisition of US-based life science company Sigma-Aldrich. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with i ... more

Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.

Sartorius is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc. The respective contract was signed today. The sales price will be determined as a multiple of the Intec division’s 2014 operati ... more

Expansion of the WALDNER Group

The WALDNER Group, with its headquarters in Wangen, and Hohenloher Spezialmöbelwerke have joined forces on the market for laboratory furniture and furniture for scientific classrooms. Both corporations can look back on a tradition of more than 100 years. Waldner (approx. 1100 employees) is ... more

LAUDA founds subsidiary in Italy

The constant temperature equipment specialist LAUDA is expanding its international reach with the creation of LAUDA Italia. The purpose of the 100% subsidiary of LAUDA Beteiligungs-GmbH is to manage the increased expansion of business in the important European market. "In this company decis ... more

All news on lab technology

Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells

A pilot study by Associate Professor Pilar Blancafort, a member of the Harry Perkins Institute of Medical Research, shows that Phylogica’s cell penetrating peptides (CPPs) linked with the Omomyc drug kill aggressive drug resistant breast cancer cells in vivo.Professor Blancafort also observ ... more

UCB secures multimillion pound funding boost from UK Government

UCB announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.The win ... more

Antibiotic resistance risk for coastal water users

Recreational users of coastal waters such as swimmers and surfers are at risk of exposure to antibiotic resistant bacteria, according to new research. In the first study of its kind, scientists at the University of Exeter Medical School have assessed the amount of water ingested during diff ... more

apceth Initiates Phase II Clinical Trial for Engineered Cell Therapy to Treat Gastrointestinal Cancer

apceth announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich.  To the company’s knowledge, thi ... more

Ebola whole virus vaccine shown effective, safe in primates

An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.The vaccine, described in the journal Science, was developed by a group led by Yoshihiro Kawaoka, a University of Wisconsin-Madison e ... more

CONTACT2015: 15th Life Science Job Fair in Heidelberg

On April 22 2015, BioContact e.V. will be organizing the CONTACT2015, the biggest life science job fair in the Rhine-Neckar region, for the 15th time in succession. 29 companies will attend the fair in the Communications Center of the German Cancer Research Center (DKFZ) in Heidelberg betwe ... more

Ablynx extends ion channel research collaboration with Merck & Co.

Ablynx announced an extension of its initial two-year research collaboration with Merck & Co., Inc., known as MSD outside the United States and Canada, to develop and commercialise Nanobody® candidates directed towards an undisclosed voltage gated ion channel.Merck & Co., Inc. will extend t ... more

Gold nanoparticles size up to cancer treatment

Treatments that attack cancer cells through the targeted silencing of cancer genes could be developed using small interfering RNA molecules (siRNA). However delivering the siRNA into the cells intact is a challenge as it is readily degraded by enzymes in the blood and small enough to be eli ... more

Medigene Starts Phase I/II Study with DC Vaccine to Treat Acute Myeloid Leukaemia (AML)

Medigene AG announced that the company's phase I/II clinical trial with its dendritic cell (DC) vaccine for the treatment of acute myeloid leukaemia (AML) has started. Oslo University Hospital, Norway, the main trial centre, has begun to identify potentially eligible patients for enrollment ... more

Sun Pharma announces closure of merger deal with Ranbaxy

Sun Pharmaceutical Industries Ltd. begins the integration of Ranbaxy’s business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. The merger has fortified Sun Pharma’s position as the world’s fif ... more

All news on pharma

Does glyphosate cause cancer?

In its recent evaluation from March 2015, the International Agency for Cancer Research (IARC), as the specialized cancer agency of the World Health Organization (WHO), came to the conclusion that glyphosate should now be classified as a carcinogenic substance in Group 2A (probably carcinoge ... more

Fecal transplants successful for treating C. difficile infection

Distasteful though it sounds, the transplantation of fecal matter is more successful for treating Clostridium difficile infections than previously thought. The research, published in Microbiome, reveals that healthy changes to a patient's microbiome are sustained for up to 21 weeks after tr ... more

Antibiotic resistance risk for coastal water users

Recreational users of coastal waters such as swimmers and surfers are at risk of exposure to antibiotic resistant bacteria, according to new research. In the first study of its kind, scientists at the University of Exeter Medical School have assessed the amount of water ingested during diff ... more

Taconic Biosciences and Cellaria Biosciences collaborate to facilitate xenograft use in oncology research

Taconic Biosciences and Cellaria Biosciences announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s methodologies ... more

Gold nanoparticles size up to cancer treatment

Treatments that attack cancer cells through the targeted silencing of cancer genes could be developed using small interfering RNA molecules (siRNA). However delivering the siRNA into the cells intact is a challenge as it is readily degraded by enzymes in the blood and small enough to be eli ... more

Saccharin shows promise as cancer inhibitor

For decades, saccharin was wrongly labeled as a possible cancer-causing chemical. Now, nearly 15 years after being declared safe, University of Florida Health researchers have found that the artificial sweetener can inhibit cancer cell growth. Saccharin shows considerable promise for its ab ... more

Protecting against memory loss with olives

It has long been proven that people who follow a Mediterranean diet and keep physically and mentally active are less likely to suffer from dementia. Olives in particular appear to play a key role in this regard. But just what are the substances contained in these small, oval fruit that are ... more

Bone Therapeutics treats first patients in ALLOB® phase IIA spinal fusion trial

Bone Therapeutics announced that the first four patients in the phase IIA proof-of-concept study for spinal fusion procedures have been treated with Bone Therapeutics’ allogeneic osteoblastic (bone-forming) cell therapy product, ALLOB®.                                                        ... more

Study Shows Liposuction Byproduct Could Lead to ED Cure

A new study appearing in STEM CELLS Translational Medicine has moved science one step closer to finding a simple treatment for erectile dysfunction (ED) after prostate cancer surgery, eschewing the usual pharmaceutical drug route with potential for harmful side effects, in favor of stem cel ... more

Spinal cord neurons that control pain and itch

The spinal cord transmits pain signals to the brain, where they are consciously perceived. But not all the impulses arrive at their destination: Certain neurons act as checkpoints and determine whether a pain signal is relayed or not. Researchers from UZH identified these neurons and their ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE